ADVANCED GENETIC SYSTEMS, INC.

Basic Information

1554 25TH AVE
SAN FRANCISCO, CA, 94122-3320

Company Profile

n/a

Additional Details

Field Value
DUNS: 154446921
Hubzone Owned: N
Socially and Economically Disadvantaged: N
Woman Owned: N
Number of Employees: n/a


  1. Mechanistic Studies of a Novel Small Molecule HIV Inhibitor

    Amount: $277,424.00

    DESCRIPTION provided by applicant There is a significant need for novel HIV therapies given the emergence of viruses resistant to existing drug regimens The Rev RRE protein RNA interaction in HIV ...

    STTR Phase I 2015 Department of Health and Human Services National Institutes of Health
  2. Point of Care Device for Molecular Detection of HIV

    Amount: $279,588.00

    DESCRIPTION (provided by applicant): There is a significant need for novel HIV therapies given the emergence of viruses resistant to existing drug regimens. The Rev-RRE protein-RNA interaction in HIV ...

    SBIR Phase I 2013 Department of Health and Human Services
  3. Identification of Anti-HIV Lead Compounds Targeting Rev

    Amount: $585,387.00

    DESCRIPTION (provided by applicant): There is a significant need for novel HIV therapies given the emergence of viruses resistant to existing drug regimens. The Rev-RRE protein-RNA interaction in HIV ...

    STTR Phase I 2009 Department of Health and Human Services
  4. A small molecule screen to target viral RNA-protein complexes

    Amount: $238,974.00

    DESCRIPTION (provided by applicant): There is a significant need for novel HIV therapies given the emergence of viruses resistant to existing drug regimens. RNA-protein complexes represent an importan ...

    SBIR Phase I 2008 Department of Health and Human Services
  5. Genetic Assay for Inhibitors of RNA-Protein Interactions

    Amount: $820,375.00

    RNA-protein interactions play critical roles in cellular regulatory processes and in the life cycles of many pathogenic viruses including HIV, hepatitis C, SARS, and West Nile virus, and thus represen ...

    STTR Phase II 2005 Department of Health and Human Services
  6. Genetic Assay for Inhibitors of RNA-Protein Interactions

    Amount: $100,000.00

    DESCRIPTION (provided by applicant): RNA-protein interactions play critical roles in cellular regulatory processes and in the life cycles of many pathogenic viruses, including HIV, hepatitis C, and We ...

    STTR Phase I 2003 Department of Health and Human Services

Agency Micro-sites

US Flag An Official Website of the United States Government